Covered recipient · General Payments record
AYESHA CHEEMA
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$4,828.81
- Reported across 291 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $364.38 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $109.76 | 6 |
| SANOFI-AVENTIS U.S. LLC | $54.98 | 2 |
| Lilly USA, LLC | $39.04 | 2 |
| Insulet Corporation | $38.44 | 2 |
| IBSA Pharma Inc. | $30.92 | 2 |
| Amneal Pharmaceuticals LLC | $26.32 | 1 |
| Ultragenyx Pharmaceutical Inc. | $25.97 | 1 |
| Amgen Inc. | $21.44 | 1 |
| Xeris Pharmaceuticals, Inc. | $17.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $21.44 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111547290 | CMS |
| Amneal Pharmaceuticals LLC | $26.32 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139182462 | CMS |
| IBSA Pharma Inc. | $15.42 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142979423 | CMS |
| IBSA Pharma Inc. | $15.50 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142973469 | CMS |
| Insulet Corporation | $18.14 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116797155 | CMS |
| Insulet Corporation | $20.30 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116821296 | CMS |
| Lilly USA, LLC | $20.17 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136062770 | CMS |
| Lilly USA, LLC | $18.87 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136059330 | CMS |
| Novo Nordisk Inc | $17.18 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096921345 | CMS |
| Novo Nordisk Inc | $23.42 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097006449 | CMS |
| Novo Nordisk Inc | $15.84 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097144126 | CMS |
| Novo Nordisk Inc | $22.72 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097742720 | CMS |
| Novo Nordisk Inc | $13.34 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096900687 | CMS |
| Novo Nordisk Inc | $17.26 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097366024 | CMS |
| SANOFI-AVENTIS U.S. LLC | $22.84 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139712398 | CMS |
| SANOFI-AVENTIS U.S. LLC | $32.14 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139712430 | CMS |
| Ultragenyx Pharmaceutical Inc. | $25.97 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153288262 | CMS |
| Xeris Pharmaceuticals, Inc. | $17.51 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144587976 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.